Why CAP Biomarker Templates are a Best Practice

Biomarker Testing

new_cap_logoBiomarker testing is an important component of cancer treatment and care. Through biomarker testing, pathologists provide clinical teams with not only diagnoses, but also valuable prognostic and predictive data.

Accurate data requires accurate reports, and thus many pathologists are turning to synoptic reporting for quality assurance. Synoptic reporting uses structured clinical templates to ensure more accurate, complete and readable reports—in less time and at a lower cost.

CAP Cancer Biomarker Reporting Templates

In 1998, the College of American Pathologists (CAP) first developed the cancer protocols that have helped to standardize pathology reporting through structured templates and consistent terminology.

Recently, CAP has begun to develop synoptic templates specifically for biomarker pathology. Biomarker reporting templates are not yet mandatory, but as more labs adopt their use, labs will need to develop best practices for biomarker testing reporting.

The CAP Cancer Biomarker Reporting Templates provide the consistent structure that helps pathologists to communicate specific, reliable and actionable information to fellow clinicians.

In December 2014, CAP updated their existing biomarker reporting templates and released six new biomarker templates.

Synoptic Reporting for Quality Assurance

Research continues to show the value of the synoptic reporting format for several clinical specializations.

Synoptic reporting enables labs to ensure accuracy and consistency in electronic medical documentation. Moreover, the right reporting software allows this data to be easily aggregated and searched for quality assurance monitoring and clinical research applications.

For example, lab administrators will be able to compile carcinoma of the breast data, analyze the prevalence of biomarkers such as ER, PR and Her2, and compare these rates across facilities.

A best practice for pathology lab administration is to use reporting software that allows biomarker testing reports to be both created and analyzed with accuracy and ease.